WASHINGTON (AP) – A new kind of flu vaccine moved a step closer to the U.S.
A groundbreaking, first-of-its-kind flu vaccine has advanced significantly towards U.S. market introduction. An FDA expert panel has approved this innovative vaccine, marking a crucial step in its regulatory journey. This development holds potential to transform flu prevention…
Market Samachar is a news aggregator. This article was originally published by ScienceAlert. Tap the button above to read the full story on their site.